Literature DB >> 20040349

Metal ion and vitamin adsorption profiles of phosphate binder ion-exchange resins.

K Takagi1, K Masuda, M Yamazaki, C Kiyohara, S Itoh, M Wasaki, H Inoue.   

Abstract

AIMS: To determine the metal ion and vitamin in vitro adsorption profile of sevelamer hydrochloride (sevelamer-HCl) and colestilan(INN)/colestimide(JAN), a novel ion-exchange resin being developed as a phosphate binder for end-stage renal disease (ESRD) patients undergoing hemodialysis, adsorption of metal ions (iron, cobalt, copper and zinc) and vitamins (B6, B12, C, K and folic acid) essential for hematopoiesis/blood coagulation was assessed.
METHODS: Mixtures of each resin (colestilan or sevelamer-HCl, 4 mg/ml) and metal ions (Fe(III), Fe(II), Co(II), Cu(II), and Zn(II), 1 microg/ml) were adjusted to pH 1.2 or 6.8 and incubated at 37 degrees C for 1 hour. Metal ions in the recovered filtrate were detected by inductively coupled plasma optical emission spectrometry. In addition, the mixtures of each resin (4 mg/ml) and vitamins (B6, B12, C, K and folic acid, 0.5 - 250 microg/ml) were adjusted to pH 6.8 and incubated at 37 degrees C for 0.5 hour. The vitamin concentrations in the recovered filtrate were quantified by HPLC.
RESULTS: Colestilan did not adsorb any metals tested at either pH level, whereas sevelamer-HCl adsorbed copper(II) and zinc(II) ion at pH 6.8 with adsorption ratios of 99% and 38%, respectively. Both resins showed almost complete adsorption of vitamin C, vitamin K, and folic acid, but weak adsorption of vitamin B6, and no adsorption of vitamin B12.
CONCLUSIONS: The differing adsorption profiles for metal ions and vitamins between sevelamer-HCl and colestilan may be of importance for the individualized management of anemia and malnutrition in chronic hemodialysis patients receiving phosphate binding ion-exchange resins for the control of hyperphosphatemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20040349     DOI: 10.5414/cnp73030

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  14 in total

Review 1.  Vitamin K effects in human health: new insights beyond bone and cardiovascular health.

Authors:  Maria Fusaro; Maurizio Gallieni; Camillo Porta; Thomas L Nickolas; Pascale Khairallah
Journal:  J Nephrol       Date:  2019-12-19       Impact factor: 3.902

2.  Clinical factors associated with serum copper levels and potential effect of sevelamer in hemodialysis patients.

Authors:  Ryota Ikee; Masataka Tsunoda; Naomi Sasaki; Naritsugu Sato; Nobuo Hashimoto
Journal:  Int Urol Nephrol       Date:  2012-06-09       Impact factor: 2.370

Review 3.  Role of Zinc in Diabetic Kidney Disease.

Authors:  Guido Gembillo; Luca Visconti; Alfio Edoardo Giuffrida; Vincenzo Labbozzetta; Luigi Peritore; Antonella Lipari; Vincenzo Calabrese; Giorgina Barbara Piccoli; Massimo Torreggiani; Rossella Siligato; Domenico Santoro
Journal:  Nutrients       Date:  2022-03-24       Impact factor: 5.717

4.  Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective.

Authors:  Mario Cozzolino; Maria Antonietta Rizzo; Andrea Stucchi; Daniele Cusi; Maurizio Gallieni
Journal:  Ther Adv Chronic Dis       Date:  2012-03       Impact factor: 5.091

5.  The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol.

Authors:  David Pierce; Stuart Hossack; Lynne Poole; Antoine Robinson; Heather Van Heusen; Patrick Martin; Michael Smyth
Journal:  Nephrol Dial Transplant       Date:  2010-10-04       Impact factor: 5.992

Review 6.  Phosphate binders in chronic kidney disease: a systematic review of recent data.

Authors:  Jürgen Floege
Journal:  J Nephrol       Date:  2016-01-22       Impact factor: 3.902

7.  Phosphate binders affect vitamin K concentration by undesired binding, an in vitro study.

Authors:  A Neradova; S P Schumacher; I Hubeek; P Lux; L J Schurgers; M G Vervloet
Journal:  BMC Nephrol       Date:  2017-05-02       Impact factor: 2.388

8.  Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?

Authors:  Lu Dai; Björn K Meijers; Bert Bammens; Henriette de Loor; Leon J Schurgers; Abdul Rashid Qureshi; Peter Stenvinkel; Pieter Evenepoel
Journal:  Toxins (Basel)       Date:  2020-05-27       Impact factor: 4.546

Review 9.  Association of Zinc Deficiency with Development of CVD Events in Patients with CKD.

Authors:  Shinya Nakatani; Katsuhito Mori; Tetsuo Shoji; Masanori Emoto
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

Review 10.  Current Therapy in CKD Patients Can Affect Vitamin K Status.

Authors:  Mario Cozzolino; Giuseppe Cianciolo; Manuel Alfredo Podestà; Paola Ciceri; Andrea Galassi; Lorenzo Gasperoni; Gaetano La Manna
Journal:  Nutrients       Date:  2020-05-30       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.